- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Amersham launches new package
Two x-ray contrast media sold by Amersham Health are now available in unbreakable bottles that are smaller and lighter than their glass equivalents. Omnipaque and isosmolar Visipaque are being packaged in the polymer bottles, which the company describes
Two x-ray contrast media sold by Amersham Health are now available in unbreakable bottles that are smaller and lighter than their glass equivalents. Omnipaque and isosmolar Visipaque are being packaged in the polymer bottles, which the company describes as being less vulnerable to accidents and easier to store. The new bottle and its contents have a three-year shelf-life. Both agents are also available in traditional glass bottles.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.
AI Adjudication Bolsters Chest CT Assessment of Lung Adenocarcinoma
April 11th 2024The inclusion of simulated adjudication for resolving discordant nodule classifications in a deep learning model for assessing lung adenocarcinoma on chest CT resulted in a 12 percent increase in sensitivity rate.
